Antibiogram of blood culture isolates of patients from a hospital in Dhaka, Bangladesh
Background: In Bangladesh, bloodstream infection is a significant cause of morbidity and mortality and empirical treatment based on clinical symptoms. Patient's final outcome might be improved with detailed and organized surveillance studies on bloodstream isolates and their resistance. Materia...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Zibeline International
2020-01-01
|
| Series: | Matrix Science Medica |
| Subjects: | |
| Online Access: | http://www.matrixscimed.org/article.asp?issn=2521-0807;year=2020;volume=4;issue=1;spage=1;epage=5;aulast=Mia |
| Summary: | Background: In Bangladesh, bloodstream infection is a significant cause of morbidity and mortality and empirical treatment based on clinical symptoms. Patient's final outcome might be improved with detailed and organized surveillance studies on bloodstream isolates and their resistance. Materials and Methods: Our study was conducted with a total of 520 suspected bacteremia patients from December 2017 to November 2018. Results: Approximately 60% and 49% of the suspected cases were male and in the age group 17–50 years, respectively, with increasing prevalence found from May 2018 to November 2018, whereas, highest was found in July 2018. Only 11.15% of the patients showed blood culture positive outcomes with 74% were Gram-negative and 26% were Gram-positive. Highest drug resistance was found with azithromycin against all the isolates, except for Staphylococcus aureus that showed 50% resistance. Among 58 isolates, 57 and 56 isolates were found sensitive to imipenem and amikacin, respectively. However, all the tested isolates were found 100% sensitive against fourth generation, cefepime, and piperacillin/tazobactam. There were no isolates completely resistant to all the antibiotics tested. It is alarming that 22.41% of the isolates were found multidrug resistant. Conclusion: We expect our present work will be helpful for health-care personnel to provide improved treatment, as well as the researcher and policymakers from hospital and government to take a step in reducing the irrational antibiotic practice. |
|---|---|
| ISSN: | 2521-0807 2521-0424 |